Genocea Biosciences, Inc. (GNCAQ)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
Aug 8, 2025, 4:00 PM EDT
Genocea Biosciences Market Cap
Genocea Biosciences has a market cap or net worth of $59.00 as of August 14, 2025. Its market cap has decreased by -99.00% in one year.
Market Cap
59.00
Enterprise Value
n/a
Revenue
1.91M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since February 5, 2014, Genocea Biosciences's market cap has decreased from 189.39M to 59.00, a decrease of -100.00%. That is a compound annual growth rate of -72.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 59.00 | - |
| Dec 31, 2024 | 59.00 | -99.00% |
| Dec 29, 2023 | 5.88K | - |
| Dec 30, 2022 | 5.88K | -99.99% |
| Dec 31, 2021 | 66.64M | -46.67% |
| Dec 31, 2020 | 124.96M | 130.85% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.72M |
| Veradigm | 789.71M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 608.19M |
| Glass House Brands | 543.74M |
| American Oncology Network | 393.37M |
| Northwest Biotherapeutics | 332.06M |
| CytoDyn | 300.87M |